Google+
Quote
NAVIGATION
PNHP RESOURCES

Latest PNHP News

  • Posted on Wednesday, April 22, 2015
    By Johnathon Ross, M.D. | The Blade (Toledo, Ohio)
    Your series on preposterously variable health-care prices usefully pointed out one of the key symptoms of our sick health-care system (“The cost of care,” April 5, April 12). Sadly, making prices transparent will not help to control costs, because there never will be a normal market for most health-care services.

  • Posted on Thursday, April 16, 2015
    By Dr. Philip Caper | Bangor (Maine) Daily News
    Getting health care in the U.S. often seems first and foremost to be about money. Our first encounter when seeking health care always seems to be with the billing department, not a caregiver. The problem often is about too little money.

  • Posted on Thursday, April 16, 2015
    By Stephen B. Kemble, M.D. | Honolulu Star-Advertiser
    Medicare’s “Sustainable Growth Rate” (SGR) formula, passed in 1997, required drastic cuts to physician fees annually. Each year Congress postponed the cuts in response to warnings that implementation would lead to severe problems with access to care for Medicare beneficiaries, but without changing the formula, effectively “kicking the can down the road.”

  • Posted on Thursday, April 23, 2015
    New pharmaceutical products usually enter the market at the maximum prices that the market would bear. So it was always a relief when the patents expired and patients could obtain much less expensive generic versions of these drugs.
  • Posted on Wednesday, April 22, 2015
    A half century ago, when the nation seemed ready to ensure health care for everyone, it was decided instead to establish programs for the two groups with the greatest needs: Medicare for retirees and Medicaid for the poor. It was intended that Medicare eventually would be expanded to include everyone.
  • Posted on Tuesday, April 21, 2015
    Drug manufacturers recently have been engaged in outrageous pricing practices for essential drugs that they produce - the hepatitis C drugs being an egregious example.